Northland Capmk Comments on Abacus Life Q1 Earnings

Key Points

• Northland Capmk forecasts Abacus Life's Q1 2026 earnings at $0.22 per share, with a full-year estimate of $0.62 per share, reflecting positive growth expectations.
• The stock received a new price target from Piper Sandler, reducing it from $12.00 to $10.00, while Wall Street Zen upgraded it from "hold" to "buy" rating.
• Abacus Life's recent quarterly earnings exceeded expectations with an EPS of $0.22 against a consensus of $0.16, alongside revenue of $56.23 million versus an anticipated $43.38 million.

Abacus Life, Inc. (NASDAQ:ABL - Free Report) - Investment analysts at Northland Capmk issued their Q1 2026 earnings per share estimates for shares of Abacus Life in a research note issued to investors on Tuesday, September 9th. Northland Capmk analyst M. Grondahl anticipates that the company will post earnings of $0.22 per share for the quarter. The consensus estimate for Abacus Life's current full-year earnings is $0.62 per share. Northland Capmk also issued estimates for Abacus Life's Q2 2026 earnings at $0.25 EPS, Q3 2026 earnings at $0.27 EPS, Q4 2026 earnings at $0.28 EPS and FY2026 earnings at $1.02 EPS.

A number of other equities research analysts have also issued reports on ABL. Piper Sandler dropped their price target on Abacus Life from $12.00 to $10.00 and set an "overweight" rating for the company in a research report on Wednesday, July 2nd. Wall Street Zen upgraded Abacus Life from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. One analyst has rated the stock with a Strong Buy rating and four have issued a Buy rating to the stock. According to data from MarketBeat, Abacus Life presently has an average rating of "Buy" and an average target price of $13.13.

Abacus Life Price Performance

ABL stock opened at $6.31 on Thursday. The company has a debt-to-equity ratio of 0.57, a current ratio of 0.76 and a quick ratio of 0.76. The business has a 50 day simple moving average of $5.89 and a 200-day simple moving average of $6.86. The firm has a market capitalization of $610.56 million, a PE ratio of -105.17 and a beta of 0.03. Abacus Life has a 1 year low of $4.60 and a 1 year high of $10.95.

Abacus Life (NASDAQ:ABL - Get Free Report) last posted its quarterly earnings results on Thursday, August 7th. The company reported $0.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.06. The business had revenue of $56.23 million during the quarter, compared to analyst estimates of $43.38 million. Abacus Life had a positive return on equity of 17.65% and a negative net margin of 0.72%.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the business. AlphaQuest LLC acquired a new position in Abacus Life during the second quarter worth $25,000. Darwin Wealth Management LLC acquired a new position in Abacus Life during the second quarter worth $27,000. Raymond James Financial Inc. acquired a new position in Abacus Life during the second quarter worth $34,000. Legal & General Group Plc acquired a new position in Abacus Life during the second quarter worth $34,000. Finally, KLP Kapitalforvaltning AS acquired a new position in Abacus Life during the second quarter worth $41,000.

About Abacus Life

Abacus Life, Inc operates as an alternative asset manager specializing in life insurance products. It purchases life insurance policies from consumers seeking liquidity and manages policies over time via trading, holding, and/or servicing. The company was founded in 2004 and is based in Orlando, Florida.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.